| Predicting atrial fibrillation in primary care using machine learning NR Hill, D Ayoubkhani, P McEwan, DM Sugrue, U Farooqui, S Lister, ... PloS one 14 (11), e0224582, 2019 | 120 | 2019 |
| Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to metformin in the treatment of type 2 diabetes mellitus from a UK healthcare system perspective M Charokopou, P McEwan, S Lister, L Callan, K Bergenheim, K Tolley, ... BMC health services research 15, 1-11, 2015 | 49 | 2015 |
| The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus M Charokopou, P McEwan, S Lister, L Callan, K Bergenheim, K Tolley, ... Diabetic Medicine 32 (7), 890-898, 2015 | 34 | 2015 |
| Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm NR Hill, B Sandler, R Mokgokong, S Lister, T Ward, R Boyce, U Farooqui, ... Journal of medical economics 23 (4), 386-393, 2020 | 26 | 2020 |
| Anticoagulant selection for patients with VTE—Evidence from a systematic literature review of network meta-analyses AT Cohen, SE Berger, D Milenković, NR Hill, S Lister Pharmacological Research 143, 166-177, 2019 | 24 | 2019 |
| A cost-utility study of the use of pregabalin in treatment-refractory neuropathic pain J Gordon, S Lister, M Prettyjohns, P McEwan, A Tetlow, Z Gabriel Journal of Medical Economics 15 (2), 207-218, 2012 | 24 | 2012 |
| Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients T Szymanski, R Ashton, S Sekelj, B Petrungaro, KG Pollock, B Sandler, ... EP Europace 24 (8), 1240-1247, 2022 | 18 | 2022 |
| Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): study protocol for a randomised … NR Hill, C Arden, L Beresford-Hulme, AJ Camm, D Clifton, DW Davies, ... Contemporary clinical trials 99, 106191, 2020 | 16 | 2020 |
| Sex differences in oral anticoagulation therapy in patients hospitalized with atrial fibrillation: a nationwide cohort study KK Lee, D Doudesis, R Bing, F Astengo, JR Perez, A Anand, S McIntyre, ... Journal of the American Heart Association 12 (5), e027211, 2023 | 11 | 2023 |
| A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting M Prettyjohns, R Sandelin, S Lister, JR Norrefalk Journal of Medical Economics 15 (6), 1097-1109, 2012 | 11 | 2012 |
| Gastroprotection in patients prescribed non-selective NSAIDs, and the risk of related hospitalization TA Koncz, SP Lister, GT Makinson Current medical research and opinion 24 (12), 3405-3412, 2008 | 11 | 2008 |
| The prevalence and management of patients with co-existing hypertension and hypercholesterolaemia in the UK B Williams, K Wilson, L Lacey, N Marchant, S Lister EUROPEAN HEART JOURNAL 25, 528-529, 2004 | 10 | 2004 |
| An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range … DE Harris, D Thayer, T Wang, C Brooks, G Murley, M Gravenor, NR Hill, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (1), 40-49, 2021 | 7 | 2021 |
| Risk of recurrent bleeding events in nonvalvular atrial fibrillation treated with vitamin K antagonists: A clinical practice research datalink study R Alikhan, C Lefevre, I Menown, S Lister, A Bird, M You, D Evans, ... TH Open 3 (04), e316-e324, 2019 | 5 | 2019 |
| The efficacy and safety of abatacept, adalimumab, etanercept and tocilizumab are comparable in polyarticular juvenile idiopathic arthritis H Rathi, B Pennington, A Amadi, S Lister, K Nanuwa Value in Health 18 (7), A636, 2015 | 5 | 2015 |
| The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales M Charokopou, P McEwan, S Lister, L Callan, K Bergenheim, K Tolley, ... Value in Health 16 (7), A441, 2013 | 4 | 2013 |
| Machine learning to detect and diagnose atrial fibrillation and atrial flutter (AF/F) using routine clinical data NR Hill, D Ayoubkhani, M Lumley, S Lister, U Farooqui, D Clifton, M O'Neil, ... Value in Health 21, S213, 2018 | 2 | 2018 |
| The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales M Charokopou, P McEwan, S Lister, L Callan, K Bergenheim, K Tolley, ... Value in Health 16 (7), A440, 2013 | 2 | 2013 |
| Incorporating time-varying clinical data into a machine learning algorithm to detect atrial fibrillation and flutter N Hill, D Ayoubkhani, M Lumley, S Lister, U Farooqui, P McEwan, ... Pharmacoepidemiology and Drug Safety 27, 372-373, 2018 | 1 | 2018 |
| Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation RJ Mulholland, F Manca, G Ciminata, TJ Quinn, R Trotter, KG Pollock, ... European Heart Journal Open 4 (2), oeae016, 2024 | | 2024 |
Dr. Nathan R. HillBristol Myers SquibbVerified email at bms.com
